Cefotiam

Specifications

61622-34-2CAS Number

680-792-8EC Number

(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidIUPAC Name

C18H23N9O4S3Chemical Formula

525.6 g/molMolecular Weight

cefotiam; 61622-34-2; Cefotiamum; Aspil; J01DC07; CHEBI:355510; (6R,7R)-7-[2-(2-amino-1,3-thiazol-4-yl)acetamido]-3-[({1-[2-(dimethylamino)ethyl]-1H-1,2,3,4-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 91W6Z2N718; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DTXSID6022763; Haloapor; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-trans)-; (6R,7R)-7-((2-(2-amino-1,3-thiazol-4-yl)acetyl)amino)-3-((1-(2-(dimethylamino)ethyl)tetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-((2-(2-amino-1,3-thiazol-4-yl)acetyl)amino)-3-((1-(2-dimethylaminoethyl)tetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-(2-(2-amino-1,3-thiazol-4-yl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-1,2,3,4-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-(2-(2-Amino-thiazol-4-yl)-acetylamino)-3-(1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo(4.2.0)oct-2-ene-2-carboxylic acid; RefChem:574975; DTXCID602763; CGP14221E; J01DA19; CGP 14221 E; 680-792-8; Cefotiamum [INN-Latin]; CTM; Cefotiam (INN); CEFOTIAM [INN]; Cefotiam [INN:BAN]; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-, (6R,7R)-; CGP 14221E; Aspil (TN); SR-01000841230; UNII-91W6Z2N718; CEFOTIAM [JAN]; CEFOTIAM [MI]; Prestwick0_000482; Prestwick1_000482; Prestwick2_000482; Prestwick3_000482; CEFOTIAM [WHO-DD]; Epitope ID:688607; CHEMBL1296; BSPBio_000343; SCHEMBL149538; SPBio_002264; BPBio1_000379; orb1982127; SCHEMBL11224134; GTPL12254; QYQDKDWGWDOFFU-IUODEOHRSA-N; HY-B0734; MSK12022; BDBM50485561; EBC-27277; DB00229; NCGC00179594-01; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid; AC183647; AB00514684; CS-0009630; NS00006913; C21544; D07648; T75297; EN300-19766378; Q3009984; SR-01000841230-2; BRD-K02275692-003-03-4; BRD-K02275692-300-01-8; BRD-K02275692-300-02-6; (6R,7R)-7-[2-(2-Amino-1,3-thiazol-4-yl)acetamido]-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-(2-imino-4-thiazolin-4-yl)acetamido-3-{1-[2-(N,N-dimethylamino)ethyl]-1H-tetrazol-5-yl}thiomethyl-3-cephem-4-carboxylic acid; 7beta-[ 2-(2-aminothiazol-4-yl) acetamido]-3-[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thiomethyl-3-cephem-4-carboxylic acidSynonyms